Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15325142Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- Neurology
NIH Funding · FY2025
Linked Award Amount
$703.4K
Full award amounts, FY2025
Award Records
1
Records listing this PI
Award-Linked Rank
#23,167
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Cynthia Sharpe as a PI. Multi-PI records show the full award amount for context.
- 5R01FD006335-03R01NEOLEV3: A Phase IIb Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures of Mild to Moderate Severity IND-109622 (September 6, 2020)$703.4Kaward amount
Award organization
Organizations that administered FY2025 awards listing Cynthia Sharpe as a PI.
FY2025 award administered by University of Minnesota (MN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Minnesota
- 2024$500K Cumulative Funding
- 2024R01 Grant Holder
- 2025$1M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Cynthia Sharpe.